Patents by Inventor Xiaobin Han

Xiaobin Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230220413
    Abstract: The present invention relates to the technical field of biology, in particular to a rice male fertility regulatory gene, the use thereof and a method for regulating rice fertility by means of using CRISPR-Cas9, and a mutant of the rice male fertility regulatory gene and a molecular marker and the use thereof. The present invention provides a rice gene GMS2 with the functions of regulating male germ cell development in rice and pollen fertility. The mutant of a rice male fertility regulatory protein GMS2 provided by the present invention can make rice pollen completely sterile, resulting in rice male sterility. The rice gene GMS2 and the mutant thereof, provided by the present invention, can be used in the sterile seed production and manufacturing of rice hybrids, thereby possessing both great application value and economic value.
    Type: Application
    Filed: December 17, 2020
    Publication date: July 13, 2023
    Inventors: Jie TANG, Tuan LONG, Chunyu WU, Jialin LI, Hao LIU, Yanqun LI, Xiaobin HAN, Xinpeng LI, Baoguang AN, Xiang ZENG, Yongzhong WU, Peijin HUANG
  • Patent number: 11208351
    Abstract: Electromagnetically-induced cement concrete crack self-healing diisocyanate microcapsules include raw materials, in parts by weight, comprising 15-55 parts of petroleum resin, 5-10 parts of paraffin, 5-10 parts of polyethylene wax, 3-10 parts of magnetic iron powder and 20-67 parts of diisocyanate. The diisocyanate microcapsules use the diisocyanate as a core material, and the petroleum resin/paraffin/polyethylene wax/magnetic iron powder mixture as the shell of the capsule. When micro cracks occur in the concrete, the crack propagation can break partial of the microcapsule inside, the diisocyanate inside the microcapsules flows out and diffuses into the crack and is subjected to a solidifying reaction with water in the concrete, so that the crack is repaired in time; and for the microcapsules that are not broken by cracks, external electromagnetic field can be applied to melt the shell to release the diisocyanate inside, thereby diffusing into cracks and solidify with water to repair them.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: December 28, 2021
    Assignee: WUHAN UNIVERSITY OF TECHNOLOGY
    Inventors: Jianying Yu, Wei Du, Shaopeng Wu, Yi Gu, Ying Li, Jun Xie, Xiaobin Han
  • Publication number: 20190300430
    Abstract: Electromagnetically-induced cement concrete crack self-healing diisocyanate microcapsules include raw materials, in parts by weight, comprising 15-55 parts of petroleum resin, 5-10 parts of paraffin, 5-10 parts of polyethylene wax, 3-10 parts of magnetic iron powder and 20-67 parts of diisocyanate. The diisocyanate microcapsules use the diisocyanate as a core material, and the petroleum resin/paraffin/polyethylene wax/magnetic iron powder mixture as the shell of the capsule. When micro cracks occur in the concrete, the crack propagation can break partial of the microcapsule inside, the diisocyanate inside the microcapsules flows out and diffuses into the crack and is subjected to a solidifying reaction with water in the concrete, so that the crack is repaired in time; and for the microcapsules that are not broken by cracks, external electromagnetic field can be applied to melt the shell to release the diisocyanate inside, thereby diffusing into cracks and solidify with water to repair them.
    Type: Application
    Filed: January 24, 2019
    Publication date: October 3, 2019
    Inventors: Jianying YU, Wei DU, Shaopeng WU, Yi GU, Ying LI, Jun XIE, Xiaobin HAN
  • Publication number: 20190202885
    Abstract: This invention provides a TauT-peptide vaccine for cancer immunotherapy and, more particularly, a method of preventing tumor carcinogenesis comprising the steps of administering to an animal and/or human subject having a precancerous precursor of various cancers, including, but not limited to, lymphoma, sarcoma, carcinoma, thymoma, and leukemia. This invention also provides a pharmaceutical preparation comprising a TauT-peptide vaccine (prophylactic and therapeutic) to prevent, suppress or inhibit spontaneous tumorigenesis in vivo. The present invention provides a safe and effective method for suppressing or inhibiting spontaneous tumorigenesis and is particularly useful for preventing subjects having elevated risk of developing p53 gene mutation associated cancers.
    Type: Application
    Filed: December 29, 2017
    Publication date: July 4, 2019
    Inventor: Xiaobin Han